ROCKET PHARMACEUTICALS, INC. (RCKT) Share-based Payment Arrangement, Expense USD 2014 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Rocket Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2023.
  • Rocket Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $10.3 M, a 15% increase year-over-year.
  • Rocket Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $40.7 M, a 21.1% increase year-over-year.
  • Rocket Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $39.4 M, a 27.1% increase from 2022.
  • Rocket Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $31 M, a 6.06% increase from 2021.
  • Rocket Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $29.2 M, a 57.5% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $39.4 M +$8.4 M +27.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $31 M +$1.77 M +6.06% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $29.2 M +$10.7 M +57.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $18.6 M +$5.2 M +38.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $13.4 M -$230 K -1.69% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $13.6 M +$12.3 M +930% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $1.32 M +$1.05 M +382% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-08
2016 $274 K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-08
2014 $7.00* Jan 1, 2014 Dec 31, 2014 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.